A year in review: Discussions in Cancer Immunity and Immunotherapy

62.3K

views

73

authors

11

articles

A year in review: Discussions in Cancer Immunity and Immunotherapy

62.3K

views

73

authors

11

articles

Editors

2

Catherine Sautes-Fridman

INSERM U1138 Centre de Recherche des Cordeliers (CRC)

Katy Rezvani

University of Texas MD Anderson Cancer Center

Impact

About

“A year in review: Discussions in Cancer Immunity and Immunotherapy” is part of a wider series of Research Topics across Frontiers in Immunology, hosted by our Specialty Chief Editors.

This Research Topic aims to spark discussion around popular spontaneous articles from 2021 in Cancer Immunity and Immunotherapy. The Cancer Immunity and Immunotherapy field is continuously evolving, therefore we are seeking to understand developments and perspectives on articles that have attracted attention throughout the year.

—---

The chosen manuscripts are :

Bispecific Antibodies: From Research to Clinical Application

TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions

Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models

GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells

Engineered Cytokine Signaling to Improve CAR T Cell Effector Function

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma

Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

—-----

This topic will be summarized by the specialty chief editors in an editorial alongside their vision for Cancer Immunity and Immunotherapy.

We welcome Opinions, Perspectives, Hypotheses and Theory, and Mini-Review article types to facilitate this discussion. Please note only papers that are relevant and add a significant contribution to the discussion articles will be considered.

Download ebook

PDF

EPUB

Share

Editors

Catherine Sautes-Fridman

INSERM U1138 Centre de Recherche des Cordeliers (CRC)

Katy Rezvani

University of Texas MD Anderson Cancer Center

Impact

62,290 Total views

38,596 Article views

23,000 Article downloads

694 Topic views

Published In

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Frontiers in Oncology

Cancer Immunity and Immunotherapy

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic